EAGLE PHARMACEUTICALS, INC. 4
4 · EAGLE PHARMACEUTICALS, INC. · Filed Jun 12, 2017
Insider Transaction Report
Form 4
Meyers Peter A.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2017-06-12$71.49/sh+350$25,021→ 350 total
Footnotes (1)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.4414 to $71.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.